These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 21642738)
1. Navigating the complexity of ulcerative colitis: challenging case example. Lees M; Regier L; Jensen B Can Fam Physician; 2011 May; 57(5):568-72. PubMed ID: 21642738 [No Abstract] [Full Text] [Related]
5. [Current medical treatment of inflammatory bowel disease]. Bosques-Padilla F Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494 [No Abstract] [Full Text] [Related]
6. Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre. Aloi M; Di Nardo G; Conte F; Mazzeo L; Cavallari N; Nuti F; Cucchiara S; Stronati L Aliment Pharmacol Ther; 2010 Oct; 32(8):1017-22. PubMed ID: 20937047 [TBL] [Abstract][Full Text] [Related]
7. [Difficult therapy of chronic inflammatory bowel diseases. No symptoms, but sequelae instead?]. Vetter C MMW Fortschr Med; 2003 Jan; 145(3-4):14. PubMed ID: 12619227 [No Abstract] [Full Text] [Related]
8. [Pharmacotherapy in patients with ulcerative colitis]. Scherer M; Hardt J; Blozik E; Preiss JC; Bokemeyer B; Hüppe A; Raspe H Z Gastroenterol; 2011 Jul; 49(7):820-6. PubMed ID: 21766260 [TBL] [Abstract][Full Text] [Related]
9. Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis? Burakoff R Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S202-3. PubMed ID: 18816760 [No Abstract] [Full Text] [Related]
10. Effectiveness of infliximab in Brazilian children and adolescents with Crohn disease and ulcerative colitis according to clinical manifestations, activity indices of inflammatory bowel disease, and corticosteroid use. Tiemi J; Komati S; Sdepanian VL J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):628-33. PubMed ID: 20386321 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441 [TBL] [Abstract][Full Text] [Related]
12. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Talley NJ; Abreu MT; Achkar JP; Bernstein CN; Dubinsky MC; Hanauer SB; Kane SV; Sandborn WJ; Ullman TA; Moayyedi P; Am J Gastroenterol; 2011 Apr; 106 Suppl 1():S2-25; quiz S26. PubMed ID: 21472012 [No Abstract] [Full Text] [Related]
13. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids. Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262 [TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission. Wakai M; Hayashi R; Tanaka S; Naito T; Kumada J; Nomura M; Takigawa H; Oka S; Ueno Y; Ito M; Chayama K BMC Gastroenterol; 2020 Apr; 20(1):85. PubMed ID: 32245401 [TBL] [Abstract][Full Text] [Related]